Literature DB >> 2073900

In vitro susceptibility of Corynebacterium group D2 and Corynebacterium jeikeium to twelve antibiotics.

A Philippon1, F Bimet.   

Abstract

The in vitro susceptibility of 83 Corynebacterium group D2 strains and 44 Corynebacterium jeikeium strains to 12 antimicrobial agents was determined by an agar dilution technique using Mueller-Hinton agar supplemented with Tween 80 (0.025%). All strains of Corynebacterium group D2 were highly sensitive to fusidic acid, pristinamycin, teicoplanin and vancomycin (geometric mean MICs 0.047, 0.048, 0.338 and 0.396 mg/l respectively). Most of the strains were resistant to other antibiotics tested (ciprofloxacin, erythromycin, gentamicin, lincomycin, rifampin and tetracycline). However, a few strains were highly sensitive (MICs less than or equal to 0.2 mg/l). The overall pattern of susceptibility of 44 strains of Corynebacterium jeikeium was similar; the geometric mean MICs of fusidic acid, pristinamycin, vancomycin and teicoplanin were 0.234, 0.235, 0.557 and 0.652 mg/l respectively.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2073900     DOI: 10.1007/BF01967505

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  24 in total

1.  In-vitro activity of the streptogramin group of antimicrobials against Corynebacterium jeikeium and D2 coryneform bacteria.

Authors:  M K Arora; M J Robbins; J Holton; D Felmingham
Journal:  J Antimicrob Chemother       Date:  1989-03       Impact factor: 5.790

2.  Corynebacterium jeikeium (group JK) resistance to ciprofloxacin emerging during therapy.

Authors:  P G Murphy; W P Ferguson
Journal:  J Antimicrob Chemother       Date:  1987-12       Impact factor: 5.790

3.  [Corynebacterium group JK endocarditis after cardiac surgery].

Authors:  Y Peloux; J Garaix; M Brunet
Journal:  Presse Med       Date:  1983-03-19       Impact factor: 1.228

4.  Antimicrobial susceptibility of Corynebacterium group D2.

Authors:  M Santamaría; C Ponte; I Wilhelmi; F Soriano
Journal:  Antimicrob Agents Chemother       Date:  1985-12       Impact factor: 5.191

5.  In-vitro activity of LY146032 daptomycin and other agents against JK diphtheroids.

Authors:  S F Dealler
Journal:  J Antimicrob Chemother       Date:  1988-06       Impact factor: 5.790

6.  Susceptibility of urinary isolates of Corynebacterium group D2 to fifteen antimicrobials and acetohydroxamic acid.

Authors:  F Soriano; C Ponte; M Santamaría; A Torres; R Fernández-Roblas
Journal:  J Antimicrob Chemother       Date:  1987-09       Impact factor: 5.790

7.  [Corynebacterium group D2. Clinical study, biochemical identification and antibiotic sensitivity].

Authors:  N Marty; D Clave; B Cancet; S Henry-Ferry; J Didier
Journal:  Pathol Biol (Paris)       Date:  1988-05

Review 8.  Infections caused by antibiotic-resistant Corynebacterium group D2.

Authors:  F Soriano; R Fernández-Roblas
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-06       Impact factor: 3.267

Review 9.  Corynebacterium JK: a cause of nosocomial device-related infection.

Authors:  W Riebel; N Frantz; D Adelstein; P J Spagnuolo
Journal:  Rev Infect Dis       Date:  1986 Jan-Feb

10.  [Role of Tween-80 used in the culture of cutaneous corynebacteria (JK group) on the composition of cellular fatty acids].

Authors:  J Chevalier; M T Pommier; A Crémieux
Journal:  Ann Inst Pasteur Microbiol       Date:  1987 Jul-Aug
View more
  18 in total

1.  In vitro activity of 79 antimicrobial agents against Corynebacterium group D2.

Authors:  J A García-Rodriguez; J E García Sánchez; J L Muñoz Bellido; T Nebreda Mayoral; E García Sánchez; I García García
Journal:  Antimicrob Agents Chemother       Date:  1991-10       Impact factor: 5.191

2.  Antimicrobial susceptibility pattern of Corynebacterium striatum.

Authors:  L Martínez-Martínez; A Pascual; K Bernard; A I Suárez
Journal:  Antimicrob Agents Chemother       Date:  1996-11       Impact factor: 5.191

3.  In vitro susceptibilities of aerobic and facultative non-spore-forming gram-positive bacilli to HMR 3647 (RU 66647) and 14 other antimicrobials.

Authors:  F Soriano; R Fernández-Roblas; R Calvo; G García-Calvo
Journal:  Antimicrob Agents Chemother       Date:  1998-05       Impact factor: 5.191

Review 4.  Teicoplanin. A pharmacoeconomic evaluation of its use in the treatment of gram-positive infections.

Authors:  C M Spencer; H M Bryson
Journal:  Pharmacoeconomics       Date:  1995-04       Impact factor: 4.981

5.  Comparison of E-test with broth microdilution and disk diffusion for susceptibility testing of coryneform bacteria.

Authors:  L Martínez-Martínez; M C Ortega; A I Suárez
Journal:  J Clin Microbiol       Date:  1995-05       Impact factor: 5.948

6.  Comparison of antimicrobial susceptibilities of Corynebacterium species by broth microdilution and disk diffusion methods.

Authors:  K Weiss; M Laverdière; R Rivest
Journal:  Antimicrob Agents Chemother       Date:  1996-04       Impact factor: 5.191

7.  Antimicrobial susceptibilities of Corynebacterium species and other non-spore-forming gram-positive bacilli to 18 antimicrobial agents.

Authors:  F Soriano; J Zapardiel; E Nieto
Journal:  Antimicrob Agents Chemother       Date:  1995-01       Impact factor: 5.191

8.  Comparative in vitro activities of new quinolones against coryneform bacteria.

Authors:  L Martínez-Martínez; A I Suárez; M C Ortega; E J Perea
Journal:  Antimicrob Agents Chemother       Date:  1994-06       Impact factor: 5.191

9.  Urinary tract infection with Corynebacterium urealyticum in South Africa.

Authors:  D Walkden; K P Klugman; S Vally; P Naidoo
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-01       Impact factor: 3.267

10.  In vitro activities of ketolide HMR 3647, macrolides, and clindamycin against Coryneform bacteria.

Authors:  L Martínez-Martínez; A Pascual; A I Suárez; E J Perea
Journal:  Antimicrob Agents Chemother       Date:  1998-12       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.